StemCells, Inc.

(NASDAQ:STEM)

1.58

+0.02 (1.28%)

Jan 08 - Close

Open
1.50
High
1.63
Low
1.50
Vol.
1.70M
Mkt Cap
126.59M
52Wk High
2.48
52Wk Low
0.66
Avg. Vol.
2.11M
P/E (Trailing)
-4.93
Beta
0.00
Short %
5.50%
Div. Yield
—

After-Hours 1.58 0.00 (0.00%) Thu, 8 Jan 2009 7:40 PM

Company Profile

StemCells, Inc.

3155 Porter Drive

Palo Alto, CA 94304

United States - Map

Phone: (650) 475-3100

Fax: (650) 475-3101

Website: www.stemcellsinc.com

State of incorporation: Delaware

CEO: Martin M. McGlynn

Employees: 63

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Proprietary techniques for encapsulation of sells

A biopharmaceutical company, which is engaged in the discovery and development of cell-based therapeutics to treat damage to,or degeneration of major organ systems.

Recent news for STEM

Members owning STEM also own

IVAC (50.00%), POT (50.00%), AAPL (50.00%), SOL (50.00%), FMCN (50.00%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning STEM

* Average monthly return vs. S&P 500

Recent opinions on STEM

More opinions on STEM »